{{Rsnum
|rsid=2071023
|Gene=PCK1
|Chromosome=20
|position=57560878
|Orientation=plus
|GMAF=0.393
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=LOC101927842,PCK1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 21.5 | 49.2 | 29.2
| HCB | 42.2 | 31.1 | 26.7
| JPT | 52.3 | 34.1 | 13.6
| YRI | 55.6 | 39.7 | 4.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 42.2 | 31.1 | 26.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}rs2071023 increases susceptibility to Type II Diabetes 1.27 times for carriers of the G allele {{PMID|17192490}}

{{PMID Auto
|PMID=21673421
|Title=Genetic factors in risk assessment for the development of type 2 diabetes mellitus in a small case series
}}

{{PMID Auto
|PMID=19725958
|Title=The promoter polymorphism -232C/G of the PCK1 gene is associated with type 2 diabetes in a UK-resident South Asian population.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}